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ABSTRACT 
Immunoassay systems are recognized as superior modalities for detecting biological 
substances. Immunoassay sensing offers the advantages of selectivity and sensitivity. 
Development of a portable micro-immunoassay system is quite desirable for fieldwork 
applications. The basis of such portable sensing approach would combine molecular 
printing techniques with solid-state devices. In this work, I report on advances in 
attaching and patterning antibodies on Si02 substrates with the aim of retaining their 
biological functionality. The integration of functional antibodies with conventional 
photodetectors through direct printing onto the oxide layer of the detector will result in a 
device with on-chip readout. To that effect, monoclonal IgG antibody was printed onto 
chemically modified and thermally oxidized silicon substrates. Using a generic 
immunoassay, I was able to validate the activity of the antibody adsorbed on epoxy-
terminated silane surface coatings. An assay based on Mouse anti-biotin - Biotin 
conjugated to horseradish peroxidase interaction was used to show the activity of printed 
antibody, specifically the molecular orientation of the antibody, on the silane-coated 
surface. In addition, avalanche photodiodes were used as solid-state detector for light 
detection. Avalanche photodiodes were able to detect the chemiluminescence, an 
indication of the sensitivity of the sensor for the immunoassay. Furthermore, there were 
clear differences between 'control' measurements obtained using a saline buffer solution 
compared to actual measurements obtained from antibody attachment to the surface of 
the sensor. This difference in signals is an indication that protein-protein interaction 
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occurred. To that effect, on-chip readout, namely in situ measurement of light detection 
without the aid of additional detector, was shown. 
In summary, I present, as a proof of concept, one example of immunoassay-based 
microsensing through the integration of antibody with avalanche photodiodes. This may 
have potential application in designing commercial, low cost, and portable biosensors. 
11 
CHAPTERl 
REVIEW OF IMMUNOASSAY-BASED BIOSENSORS 
1.1 INTRODUCTION 
Biosensors are analytical tools that are used widely in the food industry, clinical 
diagnostics, agricultural fieldwork, and biomedical research. Research in this area is 
focused toward advancing the detection modalities commonly used for signal monitoring. 
Because of the vast amount of research in this area, our focus in this project is on affinity-
based biosensors that exploit antibody-antigen interaction with the aim of implementing a 
sensitive detection modality. Biosensors based on antibody-antigen interactions are 
commonly referred to as immunoassay-based sensors, or immunosensors. Common 
immunoassay detection modalities rely on charged couple device technology as well as 
surface plasmon resonance methods for antibody-antigen detection. To that effect, I 
intend for this project to provide another detection modality that is optically based with 
high sensitivity and that can be interfaced directly with antibody. In this chapter, I 
provide an overview about research efforts being made on immunoassay-based 
biosensors, namely on the detection modality and the immobilization of protein to the 
sensor. In addition, I present some examples of commercial biosensors and outline our 
approach for designing an immunoassay-based biosensor. 
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1.2 OVERVIEW OF BIOSENSORS 
Biosensors are analytical devices composed of a detecting element and a transducer. The 
detecting element can be molecular or cellular based components such as enzymes, 
antibodies, or whole cells such as bacteria (Reviews [1-3]). The transducer element can 
be based on a charge-coupling device (CCD), photodiodes, surface plasmon resonance, or 
quartz crystal microbalance (QCM). With the exception of QCM, all mentioned 
transducers are optically based techniques while QCM is based on gravimetric 
measurement, which monitors the mass variation of a quartz chip due to the adsorption of 
protein from solution onto the sensor surface. An illustration of a typical biosensor design 
is shown in figure 1.1. 
/ Signal ® @ ◊ • 6 . 6 @- Biomolecules 
◊6 · @ - Transducer - ◊. 
66 
• 
Analytes ~ solution )( . No Signal 
Figure 1.1 - Components of a typical biosensor. As depicted, specificity is a key property for a 
biosensor. (Redrawn from M. Keusgen [4]). 
As figure 1.1 illustrates, the design of a biosensor requires the integration of the 
biomolecules with the detection element. A reliable biosensor is a device that produces 
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low false positive signal and is able to detect minute (nanomolar-picomolar) amounts of 
target molecules being measured. False positive readout is the result of the non-
specificity of the probe in the biosensor to multiple targets. Often we look at the 
probability of having a false readout and the intent is to minimize such probability. A 
curve known as the Receiver Operation Characteristics (ROC-curve) describes the 
change in sensitivity of a biosensor with the false positive readout. In addition, specificity 
is inherent in the affinity of the biomolecules to its target. On the other hand, sensitivity is 
mostly based on the ability of the transducer to measure a signal that is the result of a 
minute amount of the target. In the following paragraphs, a discussion on the type of 
biomolecules and transducers used is presented. 
Biomolecules often used in biosensors can be enzyme, DNA, antibody, cellular receptor, 
aptamer1, whole cells and so on [4-7]. Enzyme-based biosensors are widely used and one 
commercial example is the Abbot-Medisense® blood glucose meter. Glucose oxidase is 
immobilized on the sensing surf ace and the measurement is based on the oxidation of 
glucose in the blood catalyzed by the enzyme. Electrons generated from the oxido-
reduction reaction create a current which is a function of the glucose level in the blood 
[l]. 
Antibodies are used in this project due to their ubiquitous use as biomarkers in clinical 
research. Antibodies are proteins produced mainly by B cells of the immune system 
against specific biomolecules or small molecules referred to as antigens. The generation 
of antibody for clinical research and diagnostics has been mostly based on the 
1 Aptamers are nucleic acid sequences synthetically designed with biochemical properties resembling those 
of antibodies, namely aptamers can be specific to proteins or small molecules. 
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monoclonal antibody technology (hybridoma cell) developed in 1975 by Kohler and 
Milstein [8]. Briefly, the specific antigen is injected into a host (e.g. mouse, goat, or 
rabbit) leading to an immunogenic response. Antigen-specific plasma cells are isolated 
from the host and fused with cancerous cells creating hybrid cells. Monoclonal antibodies 
are then purified using chromatography techniques from hybrid cells. The advancement 
of recombinant technology has paved the way for new techniques such as phage display 
or ribosomal display whereby a large library of antibodies can be designed. Indeed, the 
generation of antibody through phage display has been done and the process is cheaper 
and less time consuming than monoclonal antibody technology. However, purification 
and selection of specific antibody can be a laborious process [5]. At least 10,000 
antibodies are available commercially. Antibodies are classified into five class families 
based on the type of heavy chains. I have used immunoglobulin G (IgG) in this project. 
One difference between IgG and the rest of all immunoglobulins is based on the type of 
heavy chain used or the number of antigen binding sites. A typical structure of an IgG 
antibody is shown in figure 1.2. 
Figure 1.2 - Structure of an IgG. Shown are the variable and constant domains. Variable chains 
(V H and V L) form the antigen binding site. 
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As depicted, each antibody is composed of two heavy chains, linked by disulfide bonds, 
and within each heavy chain there are four proteins domains ( one variable domain (V H) 
and three constant domains (CH)). There are two light chains in an IgG structure and each 
light chain is composed of two protein domains (a variable domain (VL) and a constant 
domain (CL)). Each light chain is linked to a heavy chain via a disulfide bond. The 
variable portions (VH and VL) of the antibody structure form the antigen-binding site, 
which there are two sites for an IgG. The antibody can be cleaved using proteolytic 
enzymes such as pepsin or papain creating at least two fragments commonly referred to 
as the Fab (antigen binding fragment, which can be mono- or divalent depending on the 
enzyme used) and an Fe portion (crystallizable or constant fragment) [3]. 
Functionally, the antibody is designed to recognize its cognate protein, i.e. antigen. One 
of the hallmarks of antibodies is their high binding affinity to their antigen. However, 
antibodies may be cross-reactive - the ability to recognize multiple antigens of similar 
chemical structures - which remains an issue. In the context of biosensors, antibody 
cross-reactivity results in a false positive readout. Antibody-antigen interactions are often 
associated with affinity constants that describe the tight binding of the antigen. The 
sensitivity of antibody-based biosensors is rather high indicated by the low value of KM = 
10-18 that can be achieved. In other words, picomolar concentration of antigen in solution 
can be detected using antibodies. 
As mentioned earlier, immunoassays are techniques based on antibody-antigen affinity 
used for the detection of antigen in solution. One of the most common immunoassay used 
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m screenmg for specific antigens 1s enzyme-linked immunosorbent assay (ELISA). 
Typically, target molecules (hereafter analyte(s)2), either immobilized on a solid substrate 
or dissolved in solution, are detected using functionalized antibodies. An illustration of 
common immunoassay techniques is shown in figure 1.3. 
(a) (b) 
0 - Fluorescent molecule 
9 ◊ - Antigens 
, 
y - Antibody 
- - Substrate 
Figure 1.3 - Immunoassay techniques. A generic immunoassay is shown in panel (a) while a 
sandwiched immunoassay is depicted in panel (b ). Antibody as well as antigen can be tagged with 
fluorescent molecules. 
Depending on the type of immunoassay, antibodies or antigens can be conjugated with 
fluorophores ( e.g. Cy5 (red), Cy3 (green), FITC (green), Rhodamine conjugated 
fluorophores, etc), radioactive elements, or enzymes such as peroxidase. The 
visualization of antibody recognition of its cognate is done using fluorescent microscopy, 
autoradiography film, phosphoimager, or Forster resonance energy transfer methods [5, 
9]. Following a calibration curve, the intensity of fluorescent light generated is a function 
of the concentration of the analyte in solution. 
2 I use the term ' analyte' instead of ' antigen' in immunoassay-based sensor as analytes can be more general 
since an antigen can be a protein, small molecule or even an antibody. Hence the use of analytes to avoid 
confusion 
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The use of immunoassay with a detection method constitutes the immunoassay-based 
biosensor being sought. The specificity of this sensor is governed by the biomolecules on 
the surface of the transducer element. The immobilization process is critical to the 
function of the antibody. Indeed, surface chemistry of the substrate has long been thought 
to affect the activity of the protein adsorbed on the surface of solid substrates [10]. The 
chemical nature of a surface affects the orientation of antibody as well as the amount of 
protein adsorbed to the surface of the substrate [11-13]. The choice of surface chemistry 
and therefore the immobilization process of probe molecules will have an effect on the 
sensitivity of the immunoassay-based microdevice. In the forthcoming section, surface 
chemistry of the substrate is discussed. 
1.3 PROTEIN IMMOBILIZATION 
The immobilization of antibody to the surface of the transducer is a crucial step in the 
design of a biosensor as such step affects the orientation of the protein resulting in 
changes to the sensitivity of the biosensor [5, 11-13]. Here an overview of the surface 
modifications that has been of great use in immunoassay-based biosensors is presented. 
My intention is to present examples of surfaces and surface effects on the adsorption of 
antibody. This section contains a glimpse of what has been accomplished in surface 
chemistry for biosensors application. I limit the discussion to mostly surface 
modifications of silicon substrate, as there has been a plethora of information on 
modifying gold-based surfaces commonly used in surface plasmon resonance technique. 
In addition, our design of an immunoassay-based biosensor involves a silicon substrate. 
The adsorption capacity of proteins on bare substrates is lower than on chemically 
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modified substrates [5]. Veiseh et al. [14], using surface plasmon resonance technique, 
showed that the amount of proteins was higher on modified sensor surf ace than on bare 
sensor surface. In addition, control of protein adsorption such as orientation of antibodies 
can be controlled with chemical functionalization of substrates instead of bare substrates 
[11]. Therefore, the chemical modification of the surface of biosensors, discussed in the 
next section, is a prerequisite for protein attachment. 
1.3.1 SURFACE CHEMISTRY EFFECT ON PROTEIN ADSORPTION 
Coating compounds that self-assemble to form mono- or multi-layer (SAMs) thin films 
have been designed to immobilize antibodies via physical adsorption, non-covalent, or 
covalent attachment. Self-assembly has been widely used due its ease of implementation 
and low cost. Examples of chemicals used in self assembly are 3-
aminopropyltriethoxysilane (APTES), 3-aminopropyltrimethoxysilane (APTS), 
aminophenylsilane (APhS), 3-glycidoxypropylrimethoxysilane(GPTS), 3-
mercaptopropyltrimethoxysilane (MPTS), and many more [15, 16]. Some SAMs 
compounds are shown in figure 1.4. 
CH30' 
CH o-Si~NH 
3 / 2 
CH30 
APTES 
CH,0' 
CH o-si--{cH,...Lo-c- CH-CH, 
• / T, H \ / 
CH,0 2 O 
GPTS 
APTS APhS 
CH,0' 
CHo-Si~SH 
3 / 
CH30 
MPTS 
Figure 1.4 - Chemical structures of common silane compounds. 
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Zhang et al. studied the surface coverage of silicon oxide film by APTS and APhS [13]. 
They found that solution parameters such as concentration of monomers, time of 
immersion, temperature, and water content affect the surf ace capacity of amine present 
on the surf ace. In turn, the surf ace coverage of amine groups will affect the binding 
capacity of the monolayer for antibodies. X-ray photoelectron spectroscopy and atomic 
force microscopy were used to analyze the molecular characteristics of the amino-based 
silane coatings. It was found that APhS resulted in high surface coverage compared to 
APTS. In addition, water content changed dramatically the morphology of the silane film, 
which altered the binding capacity of amine-terminated surfaces. Other studies on 
APTES have confirmed that solution parameters previously mentioned drastically 
controlled the surface chemistry and morphology of APTES. For highest surface amine 
content, Zhang et al. proposed a low concentration of APTS as well as a time of 
incubation of 5 hrs. Vanderberg et al. [17] and Akkoyun et al. [ 18] in their studies on 
APTES showed that low monomer content but longer time of incubation (longer than 
5hours) are needed for increasing the surf ace coverage by amino groups. The low 
concentration of monomer needed for good surf ace coverage has been demonstrated for 
mercaptopropyltrimethoxysilane (MPTS). Hu et al.[19] showed that good self-assembly 
of MPTS occurred at monomer concentration of 5 mM above which surface morphology, 
characterized by surf ace roughness, was increased. Overall, these studies highlight the 
effects of solution conditions on the coating films of substrates used in protein 
immobilization. 
l 
1 
1 
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In their study on alkanethiol, Li and co-workers [12] studied the adsorption behavior 
of proteins on Carboxyl (COOR) terminated and methyl (CR3) terminated SAMs. The 
effect of temperature during the preparation of SAM was shown to affect the amount of 
lysozyme adsorbed on the surface. COOR-terminated SAMs prepared at 50 °C exhibited 
higher amount of adsorbed lysozyme in comparison to COOR-terminated SAMs 
prepared at 22 °C. On the other hand, methyl terminated SAMs showed similar protein 
adsorption characteristics independent of temperature. That is in line with many studies 
that showed proteins tend to have higher affinity to hydrophobic surfaces. Further 
evidence of the effect of surf ace chemistry on protein adsorption was illustrated by Chen 
et. al. [11]. Amine terminated and carboxyl terminated coatings on silicon oxide were 
created and the orientation of antibody on each surface was monitored using surface 
plasmon resonance. Antibody orientation was dependent on surface characteristics as 
antibody adsorbed on NR2-terminated substrate exhibited either side-on or end-on 
orientation, i.e. the antibody- binding site is exposed to the bulk solution. On the other 
hand, antibodies adsorbed on COOR-terminated surfaces were head-on orientated, i.e. Fe 
portion is exposed to the solution. A scheme illustrates antibody orientation on different 
surface chemistry shown in figure 1.5. 
(a) (b) 
Figure 1.5 - Effect of surface chemistry on antibody orientation. (Redrawn from Chen et. al.) 
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In immunoassay, end-on orientation is most preferred (Fe is down), as the sensitivity of 
the technique is unchanged because antibody-binding site is in proximity to antigen 
solution. Another effect of surface chemistry, as demonstrated in figure 1.5, is the type of 
interaction between the protein and the functional group of the surf ace. Overall, surf ace 
chemistry does affect the amount of adsorbed protein, the orientation of protein on the 
surface, and their activity. In the next section, I present a few methods used for 
attachment of antibodies. 
1.3.2 IMMOBILIZATION METHODS FOR IMMUNOASSAY 
I just described how surface chemistry could affect the adsorption of protein on solid 
substrate. This will have an effect on the sensitivity of the immunoassay-based biosensors 
by 1) determining the amount of antibody on the surface and 2) determining antibody 
functional orientation. Now the question is how we immobilize the antibody on the 
sensor surface. Numerous examples of antibody immobilization methods are readily 
available. For instance, silicon oxide surfaces coated with APTES have been widely used 
for immobilizing antibody. However, antibody attachment to APTES is unstable as the 
pH of the solution is varied. In order to provide more stable attachment, amine terminated 
surfaces can be further modified to provide a covalent attachment of antibody. Using 
ethyl-3-[1-dimethylamino-propyl] carbodiimide (EDC) and N-hydroxysuccinimide 
(NHS) allows the covalent attachment of proteins. This method allows the covalent 
attachment of antibody via an NH2 group on the antibody [14, 18, 20]. In addition, 3-
glycidoxypropyltrimethoxysilane (GPTS) has been used to immobilize protein on the 
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surface of glass. The epoxy group on the GPTS compounds provides a more stable 
attachment, covalent, of antibody to the substrate. Shin et al. [21] have used GPTS to 
covalently immobilize proteins on glass substrate. 
Another common method used to immobilize antibody on the surf ace using strong 
noncovalent binding is based on avidin-biotin interaction. Usually streptavidin or 
neutravidin is immobilized on the substrate creating an avidin layer. The avidin coating 
will serve as linker for antibody attachment via coupling of biotinylated-antibody. This 
method has been implemented in patterning antibody for immunoassay applications [18, 
22-27]. For instance, Taitt et al. [23] in their study on detection of Salmonella spp., a 
food pathogen, immobilized anti-salmonella antibody on the sensor surface via the 
avidin-biotin approach. Streptavidin was immobilized on the glass substrate and 
biotinylated anti-Salmonella spp. was linked to avidin, thereby immobilizing the antibody 
to the substrate. 
Midwood et al. [28] developed a new method for covalently attaching antibody on 
oxide layer of silicon substrate. The covalent attachment of antibody is accomplished 
using silicon samples coupled to phosphonate coating incubated in disuccinimidyl 
glutarate (DSG). Fluorescent measurement indicated the presence of rabbit antibody on 
phosphonate-coated silicon substrate. 
So far, I have presented some examples for materials used to immobilize protein on 
silica-based substrates. For high throughput screening, typically high-density protein 
arrays are needed. The latter task can be accomplished using numerous protein patterning 
methods, which are discussed in the following section. 
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1.4 PROTEIN PATTERNING FOR IMMUNOASSAY 
As mentioned previously, immobilization of antibodies onto solid surfaces is a critical 
step toward integrating biomolecules with solid-state devices in the design of biosensors. 
In immunoassay, antibodies or analytes are typically arrayed in a matrix form to increase 
surface density and screen for multiple targets. Protein patterning is done on planar 
substrates that were modified with one of the chemistries discussed previously. 
Microliters to nanoliters of protein solution are typically used. The exposed area of the 
samples, whereby proteins were not immobilized, has to be passivated to reduce the non-
specific adsorption of target molecules and improve immunoassay biosensor function. To 
prevent nonspecific adsorption, numerous chemical schemes have been developed. I 
stress that a universal surface treatment that resists adsorption of all proteins is not 
available. Rather, protein-resistant surfaces are tailored toward the type of proteins for 
which nonspecific adsorption is needed. In their effort to provide a guideline for making 
protein resistant surfaces, Ostumi et al.[29] have indicated that surfaces should have the 
following conditions: (1) surface is hydrophilic, (2) surface molecules should include 
hydrogen acceptor groups, (3) surface molecules should be void of hydrogen donor 
groups, and ( 4) overall surface charge is neutral. It is worth mentioning that these criteria 
should not be all satisfied to design protein-resistant surface. For example, Lee et al. [30] 
has reduced the nonspecific binding of proteins by coating a surface with a hydrophobic 
film based on fluorinated carbon which has the trademark name CYTOP. Lee et al.[30] 
showed that the application of CYTOP to silicon-based substrate reduced the background 
noise of the fluorescent signal due to nonspecific binding of proteins. 
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One of the popular methods used and studied for its passivation capability utilizes bovine 
serum albumin (BSA) [31, 32]. The use of BSA as a passivation layer is common in 
immunoassay techniques. Other examples of protein-resistant surf aces include 
polyethylene glycol surfaces, which have been demonstrated to reduce nonspecific 
protein adsorption in studies by Veiseh et. al. and Shin et. al. [14, 21]. In addition, 
carbohydrate layers such as chitosan and dextran have been studied to understand the 
nonspecific binding for IgG and lysozyme [18, 21]. All these biomolecule-based and 
polymer-based coatings used for reducing nonspecific protein adsorption share a common 
feature: they are highly hydrophilic. Having discussed the methods used for reducing 
nonspecific adsorption, the objective at this stage is directed toward high-density protein 
patterning methods. 
Several protein-patterning techniques have been developed for high density protein 
microarrays for immunoassay biosensors. Photochemical method [21, 33], microcontact 
printing (µCP) [34], microfluidic network (µFN) [32], and spotting or spraying [35] are 
techniques used for proteins patterning some of which are summarized in figure 1.6. 
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Figure 1.6 - Microcontact printing (a), microfluidic network (b), and electrospray deposition (c) 
are shown. For detailed description, refer to text. (Redrawn from refs. [32, 34, 35]). Several steps 
are needed to form a protein microarray using microcontact printing as shown in panel (a). In 
panel (b ), the immobilization of antibodies using microfluidic methods requires the flow of 
antibody solution and removal of microfluidic channels thereafter. Antibody-patterned substrate 
is incubated in fluorescently labeled antibodies. Fluorescent microscopy is used to image the 
substrate. Electron spray deposition technique is shown in panel ( c ). 
Although not illustrated in figure 1.6, photochemical methods rely on photolabile 
molecules to pattern a protein. The use of UV energy in the patterning of protein can be 
detrimental to the function of the protein, therefore limiting the ability of this technique. 
Microcontact printing is a technique developed by Whitesides at Harvard University 
intended to pattern curved substrates. Briefly, a polydimethysiloxane (PDMS) mask is 
fabricated using photolithographic method and then incubated in a protein solution. 
Proteins are adsorbed to the PDMS mask and excess proteins are washed away using a 
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buffer solution. The protein-loaded PDMS mask is then placed in contact with a substrate 
that will allow proteins transfer from PDMS mask to a substrate creating a protein 
pattern. Renault et al. [34] have used microcontact printing (µCP) to print protein patterns 
onto glass substrates but the patterns lacked uniformity as shown in panel (a) of figure 
1.6. Microfluidic network (µFN) is another protein patterning technique commonly used. 
This method, like µCP, uses a microchannel system made of PDMS elastomer fabricated 
using photolithography. PDMS-based channels are placed in contact with a substrate 
(gold, silica) and protein solutions are flowed through channels. Excess proteins are 
removed using a buffer solution rinse and microfluidic channels are lifted away from the 
sample. Patterned substrates are immersed in a blocking solution such as BSA. The 
presence of protein can be tested using an immunoassay technique. Delamarche et.al. 
[32] showed that the substrate and the elastomer are tightly sealed through spontaneous 
adhesion of PDMS elastomer to glass substrate. Analytes such as chicken IgG and mouse 
IgG were immobilized onto chemically functionalized glass substrates. Antibody-coated 
substrate was incubated in a solution containing Cy3-labeled anti-chicken IgG and Cy5-
labeled anti-mouse IgG antibody to validate the presence of analytes. Fluorescent 
imaging microscopy was used to analyze the samples. Panel (b) of figure 1.6 indicated 
that cross-reactivity did not take place as separate green and red colored lines were 
observed. This study illustrated the potential use of µFN as a patterning technique for 
immunoassay-based biosensor. The other technique depicted in panel (c) of figure 1.6 is 
electrospray deposition (ESD) developed by Morozov et al. [35]. ESD has been 
developed to pattern several proteins onto solid surfaces. This technique uses capillary 
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tubes to hold different protein solutions that are to be printed. Protein printing is done 
sequentially and a movable mask is used to create the pattern on the substrate. As 
depicted in the panel (c) of figure 1.6, the charged protein in the capillary follow a path 
that is maintained by the field created (between electrode and capillary) as well as the 
dielectric shield. One of the drawbacks of this technique is the loss of the activity of 
proteins being printed upon impact with the substrate [35]. Another method for patterning 
protein is based on microarray spotting which has shown great potential for immunoassay 
applications. Hence, a review of papers describing the use of microarray techniques for 
application in immunoassay-based biosensors, namely protein microarray, will follow. 
1.4.1 MICROARRA Y PATTERNING FOR IMMUNOASSAY 
Protein patterning using microarray technology has great potentials for immunoassay-
based biosensors. Microarray technology has been used widely for high throughput 
screening in genomic research and clinical diagnostics [9]. High-density protein 
microarrays should have around 10,000 spots per 25mm x 75 mm glass slide. The setback 
of using microarray for proteomics (study of the physiologic state of the cell at the 
protein level) is related to the lower functional stability of protein compared to DNA. In 
other words, retention of biological activity in the nanoliter volume of protein spotted on 
a glass slide must be sustained [5]. Surface modification of the glass slide along with 
optimized printing and solution conditions such as temperature, humidity, and ionic 
strength of buffer allow the design of functional protein microarrays. To that effect, I 
present some examples of using microarray technology for patterning proteins. 
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Microarray printing is usually performed using an automated arrayer consisting of 
capillary pins. Contact and noncontact modalities are used to transfer protein solution 
from capillaries on to modified glass slides [27]. In the former modality, capillary pins 
come in direct contact with the substrate where the latter modality uses piezolelectric3 -
based capillary pins to transfer protein solution onto glass substrate. Other venues of 
spotting microarray protein, though less popular, have previously been discussed such as 
ESD [27, 35]. I wish to discuss the use of microarray for immunoassay applications as 
has been demonstrated by several authors. 
Michaud et al. [36] used microarray technique to print about 5000 yeast proteins on 
modified glass slides in order to study antibody specificity to such proteins. Their result 
showed the potential use of microarray for screening antibody against specific antigen in 
a high throughput scheme. However, cross-reactivity of antibody was observed as certain 
antibodies were able to recognize multiple antigens, though with variable signal intensity. 
Macbeath et al. [37] also used protein microarray to study protein G and IgG interaction 
as well as other protein-protein interactions. On a modified glass substrate, quadruplicate 
of three different proteins, one of which was protein G were printed using a microarray 
printer. ProteinG-IgG interactions were validated using fluorescent microscopy 
techniques that indicated the presence of fluorescing spots due to proteinG interaction 
with IgG. The data were also an evidence that protein G retained its activity on the 
modified glass substrates used in the study by MacBeath and co-workers. In another 
study on microarray, Haab et al. [38] examined antigen-antibody interaction using 115 
3 Piezoelectric materials have the ability to undergo mechanical deformation when placed under a voltage 
source. Mechanical deformations of capillary lead to compressing the solution within the pin leading to 
ejection of droplets. 
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antibodies and their corresponding 115 antigens. In one set of experiments, the author 
spotted microarray of 115 antigens, each antigen was spotted 6-12 times. The antigen 
microarray was then immersed in a solution of 115 fluorescently labeled antibodies (two-
color scheme) solutions. Fluorescent microscopy was used to image all protein 
microarray slides and quantitative analysis was performed. Although cross-reactivity was 
observed for certain antibodies, the author identified antibodies and their cognates for 
half the number of antigens spotted on the glass substrate. This study (Haab et. al.) is a 
good example of the potential use of microarray technique for immunoassay-based 
microsensing. In a study to identify the presence of cholera toxin in a solution, 
Delehanty et al. [26] used noncontact microarray printing to immobilize anti-cholera 
toxin antibody on glass substrate. Antibody coated substrates were immersed in a Cy5-
labeled cholera toxin and detection was done using a fluorescent scanner. Recognition of 
cholera toxin was observed indicating the specificity of anti-cholera antibody to its 
cognate protein. 
All of these studies highlight the potential use of microarray technology for immunoassay 
in clinical diagnostics or drug screening. As such, microarray technology will be an 
invaluable tool in developing a high throughput immunoassay-based biosensor. 
1.5 IMMUNOASSAY-BASED BIOSENSOR 
Having described the importance of the surf ace chemistry on protein adsorption, protein 
immobilization methods, and protein patterning techniques, I provide, in this section, a 
holistic view of immunoassay-based biosensor. Some examples of immunoassay methods 
that have been used in clinical diagnostics, screening antibody specificity, and food 
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industry will be described. The focus is directed more toward the transducer component 
of immunoassay-based biosensor. 
Moremo-Bondi et al. [39] have designed an antibody-based biochip whereby 
antibodies are printed on a nylon membrane and photodiodes are used as detector 
elements. Specifically, anti-sheep IgG and anti-mouse IgG were immobilized on a nylon 
membrane in quadruplicates. Rabbit IgG was used as a control and Cy5-labeled solutions 
of mouse IgG and sheep IgG were added first separately, then in a mixed solution to the 
nylon membrane. The biochip employed a laser source to excite fluorescently labeled 
antibodies immobilized to a nylon membrane. As a detection element, Photodiodes were 
used to acquire fluorescent signals. Results indicated that photodiodes were able to detect 
the signal from each antibody spot and distinguish differences between control and 
experimental samples. In addition, no cross-reactivity of antibodies was observed. In a 
similar setup, Askari et. al. [40] used the antibody-based biochip with the sensing 
element being the photodiode array to detect protein p53, a tumor suppressor protein. 
Monoclonal p53 antibody was spotted onto nylon membrane, which was then incubated 
in a Cy5 labeled p53 protein solution. In order to verify that photodiode can detect 
multiple targets in solution, goat anti-IgG was immobilized to the nylon membrane. The 
photodiode was able to detect the multiple targets in solution. In a clinical diagnostic 
aspect, a series of anti-p53 antibody was added to human sera, which were spotted on the 
nylon membrane. Using their immunoassay, photodiodes were able to detect signals 
representing p53 presence in human sera. It should be mentioned that the nylon 
membrane whereby antibodies were printed was not physically linked to the photodiode 
31 
array. Instead, an optical lens system was needed to focus the fluorescent signal 
emanating from the nylon membrane onto the photodiode system. In our biosensors, as 
described later, the intent is to print proteins directly on the photodetectors. 
Taitt et. al. [23] as well as Yu et. al. [25] have used immunoassay-based biosensors 
for detecting the presence of Salmonella spp. and E. coli. in food samples. Taitt and co-
workers used a multianalyte array biosensor to detect the presence of Salmonella spp. 
Different analytes were immobilized on modified glass waveguides using the 
microfluidic network (µFN) method described earlier. A light source was coupled into a 
waveguide to generate an evanescent wave capable of exciting Cy5 fluorophore 
conjugated to antibodies used in the detection assay. The imaging was done using a CCD. 
Taitt et. al. were able to detect the presence of salmonella, using the multianalyte 
immunosensor, in spiked food samples. In a similar study to detect food pathogen, Yu et. 
al. employed a different immunoassay-based biosensor. Their system used functionalized 
magnetic beads on which antibodies were immobilized to probe the presence of target 
samples. The detection principle was based on electrochemiluminescence using a 
commercial photomultiplier tube. As demonstrated, immunoassay-based biosensors can 
be used as analytical tools for screening pathogens in food samples. Surface Plasmon 
Resonance (SPR) technique is by far the most widely used commercial immunoassay-
based biosensor. It has been used in a wide spectrum of areas such as in food industry, 
clinical diagnostics, protein-protein interaction studies and so on. Therefore, I wish to 
present some examples of commercial biosensors that employ SPR technique. 
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1.5.1 EXAMPLES OF COMMERCIAL BIOSENSORS 
My focus in this section is to present examples of commercial biosensors while keeping 
to the theme of the project, immunoassay-based microdevices. To that effect, the focus is 
on commercial biosensors that employ immunoassay techniques. 
Most commercial biosensors are based on the platform developed around the early 
90' s by Biacore Instrument (Sweden). The Biacore instrument, based on surface plasmon 
resonance (SPR), became the first commercial optical biosensor used for biomolecular 
analysis [41]. These systems have been used in drug discovery studies, food monitoring, 
environmental studies, and biomolecular research [42]. In addition, new SPR-based 
biosensors were introduced to the commercial market of biosensors. 
The Biacore instrument relies on the surface plasmon resonance technique. Briefly, the 
detection process is as follows: antibodies are immobilized on the gold surface of the 
Biacore structure and a solution of analyte is flowed through an elastomeric channel. An 
optical detector monitors the change in refractive index via changes in the angle of 
reflected light due to the formation of antibody-analyte complexes in solution. The 
following scheme shown in figure 1. 7 provides a better visualization of the Biacore 
system [4, 6, 43]. 
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Figure 1. 7 - Principle of SPR detection. As the light source strikes the metal surface of the glass 
substrate, surface plasmon wave is emanated from the gold material. Difference in the angles of 
reflection is related to the formation of antibody-antigen complexes in solution. 
Other commercially available biosensors developed by IAsys® Instrument, Nippon Laser 
Electronics, Texas Instruments, and IBIS Technologies are also SPR-based biosensors. 
These sensors are modified versions of the Biacore platform including user-friendly 
configurations in terms of software use, sampling, and reusability through UV /ozone 
cleaning [41]. In addition, miniaturized optically based biosensor has been designed as 
the device developed by Texas Instruments, Spreeta®, offer the maneuverability needed 
for fieldwork application. Despite all the advances in Biacore platforms, cost remains an 
issue as well as the requirement for large hardware components. Current research, e.g. the 
present work, is focused on the integration of immunoassays with microelectronic 
devices for the development of low cost and effective biosensors. High throughput 
analysis is a desired design specification and microelectronic devices based on 
complementary-metal-oxide-semiconductor (CMOS) technology are well suited for this 
purpose. With that in mind, this work is focused on the integration of antibody with solid-
state detectors, namely avalanche photodiodes introduced in chapter 3. 
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1.6 SUMMARY AND PROPOSED BIOSENSOR DESIGN 
The design of immunoassay-based microdevice requires the integration of several 
components for producing a sensitive, specific, and low cost device. 
1. Surface chemistry affects the adsorption of protein and that the stability of antibody 
immobilized on a surface can affect the sensitivity of the device. In addition, surface 
chemistry alters the orientation of antibodies on substrates. 
2. Covalent immobilization of antibody on the surface of biosensors, accomplished 
using approaches discussed in this chapter, provides stability for the biosensor in case 
of a pH change. 
3. The presence of target molecules is confirmed using labeled solution of tagged 
antibodies or tagged target molecules. The detection of analytes can be based on 
fluorescent or chemiluminescent signals. Unlike fluorescence whereby an excitation 
source is needed, chemiluminescence is emitted from a chemical reaction. The decay 
of chemiluminescence is longer than fluorescence, hence the preference for using 
chemiluminescence in this project. The detection modalities for either fluorescence or 
chemiluminescence are based on autoradiography films, fluorescence microscopy, 
photodiodes and so on. 
4. The integration of surf ace chemistry, antibodies, and detection modalities will lead to 
designing an immunoassay-based biosensor. 
Hence, these issues will be considered in the design of an immunoassay-based 
microdevice. In the section on immunoassay biosensor, with the exception of SPR, most 
techniques did not exhibit on-chip readout; that is the detector element acquires the signal 
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from antibody without employing additional element. With respect to SPR, the 
availability of such technique is hindered by the high cost of the Biacore platform. To 
that effect, I have combined the specificity of immunoassay techniques with the high 
sensitivity of avalanche photodiode in the prospect of designing a biochip with on-chip 
readout. The ability to perform single photon detection makes avalanche photodiode a 
desirable and wise choice as our sensor element. The immunoassay-based microsensor 
will also be low cost and portable for fieldwork applications. 
In the following chapter, the attachment of antibody to the oxide layer of silicon 
substrates is presented along with results on the characterization of the coupling agent 
and on protein attachment. Immunoassay techniques are used to validate the presence of 
protein on the oxide layer of silicon substrates. 
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CHAPTER2 
ANTIBODY ATTACHMENT TO FUNCTIONALIZED SILICA SUBSTRATES 
2.1 INTRODUCTION 
We have seen in the literature review that surface chemistry of substrate affects the 
adsorption of biomolecules, the orientation and the activity of the protein. In addition, the 
immobilization method for antibody is critical for the stability of the protein in case of 
pH change. I have used silicon-based substrate with an oxide layer to perform the 
attachment of antibody. In choosing a coupling agent, I have focused on using silane-
based compounds as their use for immunoassay based biosensor have been demonstrated 
[12, 18, 21]. In addition, silanization is an easy process, low cost, though can be time 
consuming. The characterization of surface coating using infrared spectroscopy and 
atomic force microscopy was also performed. Following surf ace modification and 
characterization, either mouse anti-human collagen type Nor mouse anti-biotin antibody 
was manually spotted onto the modified silicon substrate. I have used an immunoassay 
similar to ELISA to detect the presence of antibody on the surface or detect the presence 
of biotin in solution. At this step in designing the immunoassay-based microdevice, I 
have relied on autoradiography film. Mouse anti-human collagen type N retained its 
activity as radiography images showed. In addition, mouse anti-biotin antibody was 
active on the substrate as radiography film indicated the recognition of biotin in solution. 
In this chapter, experimental results on surface modification, surface characterization as 
well as on biomolecules attachment are presented. Demonstrating the ability to attach 
I 
1 
1 
1 
l 
37 
antibody onto modified oxide layer of silicon substrate will be step closer to the 
integration of biomolecules with the detection element. The proposed approach for our 
immunoassay-based microsensing design is depicted in figure 2.1. 
Avalanche photodiode 
y _ 1 ° Antibody 
Y-2° Antibody 
• - Horse Radish Peroxidase 
conjugated to 2° Antibody 
ECL ➔ Electrochemiluminescent 
Figure 2.1 - Proposed design for a portable, on-chip readout immunoassay-based sensor. 
2.2 SUBSTRATE MODIFICATION 
In this section, sample preparation as well as the characterization of functionalized 
substrates will be discussed. First, the procedure for substrate preparation is presented. 
I have used silane compounds namely glycidoxypropyltriethoxysilane (OPTS). OPTS is a 
known adhesive in the metal coating industry [44]. The silanization of OPTS follows a 
three-step mechanism as was proposed by McGovern et. al. in their study on 
Octadecyltrichlorosilane (OTS) [45]. The silanization mechanism for OPTS may 
resemble the mechanism of OTS involving a hydrolysis step (i.e. formation of silanetriol 
by hydrolyzing the -OCH3 groups on OPTS), followed by adsorption of the silanetriol 
onto the substrate forming Si-0-Si bonds. Antibody immobilization using OPTS 
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provides a covalent linkage between the sensor surf ace and biomolecules. The attachment 
of antibodies using GPTS is more stable compared to using APTES, which provides 
noncovalent attachment of biomolecules [5]. The epoxy group on GPTS coated surface 
reacts with an amino group on the protein as figure 2.2 shows. 
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Figure 2.2 - A scheme for antibody attachment on GPTS coated silicon substrate. The 
silanization process occurs via a three-step mechanism as explained in the text. Regarding 
antibody attachment, any amine group on the antibody could react with the epoxy group on the 
substrate, although the location of NH2 on the antibody as shown here is more desirable for our 
immunoassay. 
Avalanche photodiodes, i.e. detection element, are based on silicon substrate. Therefore, 
silicon based substrates were used on which an oxide layer was grown using thermal 
oxidation technique to facilitate chemical attachment of GPTS. Silicon (Si) substrates ( 4 
in2) were cleaned in a piranha solution (1:5 v/v H2O2:H2SO4) for 10 min. and immersed 
in a concentrated hydrofluoric acid (HF) solution to etch away surf ace coatings. Si 
samples were blown dried with N2 and placed in an oven for oxidation. Thermal 
oxidation was done for 1 hr, which resulted in an estimate oxide layer thickness of 500 
nm. Following thermal oxidation, Si samples were cooled and few samples were selected 
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to measure the thickness of the oxide layer using an optical interference technique. On 
average, a thickness of 0.5 µm thin film of oxide was observed. Oxidized Si substrates 
were then diced into I in.2 samples and cleaned in 1:5 (H2O2:H2SO4) piranha solution for 
10 min. This was followed by a thorough DI H2O rinsing and immersing the samples in 
1: 100 HF solution for 1 min. It is thought that the dilute HF cleaning will increase the 
amount of hydroxyl group on the oxide surface, thereby increasing the immobilization 
capacity of the surface. A thorough DI H2O rinsing followed the dilute HF treatment. 
Samples were dried under a stream of N2 and were stored in a desiccator under vacuum 
prior use. 
Silicon substrates (lin2) were immersed in 2% (v/v) solution GPTS in hexane for 5hrs 
with agitation. The previous conditions were determined from FTIR characterization. 
Following, GPTS-coated substrates were rinsed twice with hexane and twice with 
acetone. The substrates were dried with a stream of N2 and were used immediately for 
protein attachment. Prior to introducing the procedure of antibody attachment to the 
GPTS-coated silicon substrates, I present the characterization of the surf ace coating. 
2.3 GPTS COATING CHARACTERIZATION 
In characterizing APTS coating of silicon substrates, Zhang et al. studied the effect of 
solution parameters on surface coverage and morphology which has been shown to affect 
protein adsorption [12]. X-ray photoelectron spectroscopy was used - a technique based 
on the interaction of x-ray with a material, capable of performing elemental composition 
of the surf ace - to determine the NH2 coverage of the surf ace. XPS data are displayed in 
terms of signal intensity versus photoelectron energy, corresponding to each element on 
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the surface such as N, C, 0, and so on. I have followed in similar footsteps of this study, 
i.e. characterization of surface and morphology, for GPTS coating. The characterization 
of GPTS with XPS would not be suitable, as the amount of oxygen atoms within a 0.5 
µm-thick oxide layer far exceeds the amount of Oxygen within the epoxy ring of GPTS 
monomers. Instead, Fourier Transform Infrared Spectroscopy (FTIR) was used to 
characterize the presence of epoxy groups on the oxide layer of the silicon substrates. 
Regarding GPTS, the presence of epoxy and methyl group as shown in its molecular 
structure would be used to identify the presence of GPTS coating on the surface. 
I have focused on studying the effect of monomer concentration and time of incubation 
on the coverage and surface chemistry. The coating process was done in a similar fashion 
as the preparation of silicon done previously. The samples in this case were prepared 
differently because the FTIR configuration used was in a reflection mode. Specifically, I 
have used reflection-absorption infrared spectroscopy (RAIRS) configuration to 
characterize qualitatively the presence of epoxy group on substrates. Nicolet Magna IR, 
50 Spectrometer, Series rr® was used for FTIR measurements. Solution conditions used 
to prepare the samples are summarized in table 1. 
Table I - Experimental conditions for FTIR experiment. 
Parameter: Time Parameter: GTS Concentration 
Time (hrs) [GTS] (% in hexane) Water(% v/v) Time (hrs) [GTS] (% in hexane) Water(% v/v) 
2 2 <0.01 5 0.2 <0.01 
5 2 <0.01 5 2 <0.01 
8 2 <0.01 5 4 <0.01 
12 2 <0.01 5 8 <0.01 
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As mentioned, samples used for the FTIR study were not based on silicon; instead, I have 
used glass substrates that were coated with a thin film of gold (Au). Thin films of silica 
were grown on Au and were plasma cleaned prior to the acquisition of background silica. 
Sample preparation and FTIR analysis are summarized in figure 2.3 . 
,------__________ j _ --------------, 
: Coat samples with GPTS. : 
: 3 samples per a set of solution : 
: conditions. : 
1 ____ --- --- --- -- --- --- -- --- ----- - I 
-
·------ --- ------- ------------, 
: Acquire FTIR spectra in : 
: RAIRS configuration. : 
• - -- --- --- --- --- --- -- --- -- - -- I 
Figure 2.3 - Flow chart for FTIR measurements and analysis. 
. ----------------------------- ----
: Acquire Silica spectra and : 
- : background spectra for all : 
i samples. : 
----------------] --------------· 
·------------------------------ --
: Background subtraction : 
- : Average spectra for a given : 
: solution parameter. ___________ : 
FTIR spectra for silica background and neat GPTS on KBr pellets were acquired. The 
presence of a SiOSi peak in the FTIR spectrum shown in figure 2.4 showed that gold thin 
films were coated with Silica. 
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Figure 2.4 - FTIR spectra for silica grown on gold and neat GPTS on KBr pellets. The silica 
presence on Au layer is indicated by the strong SiOSi vibration. For GPTS, the absence of 
SiOCH3 shown around 820 on silicon will indicate the presence of the coating. 
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The 'neat' GPTS spectrum shown in panel (b) of figure 2.4 indicates the presence of the 
epoxy group at 910 cm-1 and the presence of Si-OCH3 vibrational mode around 820 cm-1• 
In coating silica layer with GPTS, we expect the strong FTIR signal around 820 cm-1 to 
decrease. GPTS coating was done in a glass Petri dish for each solution condition (3 
samples). All samples were plasma cleaned for 2 min 30 sec prior immersion into GPTS 
solution. The incubation time and GPTS concentration were chosen as indicated in table 
1. Substrates coated with GPTS were stored in a desiccator prior to FTIR analysis. FTIR 
data for time and concentration effects on GPTS coating of silica layer are shown in 
figure 2.5. Each FTIR spectrum shown here is the average of three measurements. 
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Figure 2.5 - FTIR data on GPTS coated substrates. Time and concentration variations are 
illustrated. Spectra shown for each solution condition are the average of three replicates. 
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Concerning the FTIR data, the signals of interest are indicated by arrows shown in figure 
2.5. Epoxy vibrational frequency occurs around 910 cm-1 (second arrow from the right in 
figure 2.5) clearly indicating the presence of OPTS on the surface. In addition, the 
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decrease in the signal corresponding to SiOCH3 vibration is apparent in figure 2.5. This 
clearly indicates that GPTS reacted with the hydroxyl groups on the oxide layer grown on 
gold. Another indirect indication for the GPTS coating is the Si-O-Si bond peak around 
1100 cm-1 and the C-H vibration in the range of 2840-2940 cm-1• The other signal shown 
in figure 2.5 represents the vibrational frequency for hydroxyl (OH) vibration. The 
incubation time for silica-based samples in GPTS coating varied from 2 hrs up to 12 hrs. 
It is clearly observed around 910 cm-1 that longer time will increase the amount of epoxy 
group on the surface. In terms of concentration of GPTS monomer, less than 2% GPTS 
solution is desirable for good surface coverage. This is in agreement with data published 
in the literature on APTES, APTS, and MPTS [13, 17-19]. High concentration of silane 
monomers in solution results in the polymerization of the silane in the bulk reducing the 
amount of SiOCH3 for reaction with oxide layer. From these findings, a time of 5hrs and 
a 2% GPTS concentration in hexane was used in subsequent work. 
Atomic force microscopy (AFM), a surf ace imaging technique, was used to study the 
surface morphology of GPTS-coated oxide layer of silicon samples. Specifically, tapping 
mode-AFM was used to image the surface of GPTS-coated substrate and measure surface 
roughness. Samples in this case were 0.25 in2 Si/Si02 prepared as follows: oxidized 
silicon substrates with 1 in2 surface area were diced into 0.25 in2 samples to fit in the 
instrument. The newly cut samples were cleaned as described previously for coating 
GPTS for lin2 samples. Cleaned oxidized silicon substrates (0.25 in2 surface area) were 
then immersed in a 2% GPTS solution for a time of 5hrs with varied water concentration. 
AFM analysis was performed following the coating of the samples. Scan areas of 0.25 
45 
µm2 and 0.25 nm2 were imaged for a background sample ( cleaned Si/Si02) and OPTS-
coated Si sample. AFM images obtained using Dimension 3100 AFM® (Digital 
Instrument, Veeco Metrology Group) with scanning areas of 0.25 nm2 are summarized in 
figure 2.6. 
(a) SiO2 Surface (b) GTS-coated SiO2 Surface 
(<0.01 %H20) 
Figure 2.6 - AFM images of bare SiO2 and GPTS-coated silicon oxide layer. The roughness of 
SiO2 and GPTS coating were 0.120 nm, and 0.245 nm, respectively. 
The roughness values in this case were 0.12 nm and 0.245 nm for Si02 and GPTS-
coating, respectively. In panel (b ), aggregated structures of OPTS, which are 
characteristic of self-assembly of silane compounds, are observed. 
Having determined the reaction condition for OPTS coating for oxide layer of silicon 
substrates, antibody attachment was performed on modified samples. The presence of 
antibody on substrates was determined using an immunoassay technique. 
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2.4 IMMUNOASSAY MEASUREMENTS 
In this section, a description of the protein attachment procedure is presented followed by 
immunoassay data on antibody attachment to GPTS-coated silicon substrates. In addition, 
the activity of the antibody on the surface was determined using an assay based on the 
interaction between Mouse anti-biotin lgG and biotin conjugated to HRP. 
2.4.1 EXPERIMENTAL PROCEDURE 
A solution of 1:500 Mouse anti-human collagen type N lgG (1° Ab) dissolved in 
phosphate saline buffer (PBS, pH ~ 7.4-7.7) was spotted using a micropipette on the 
chemically modified silicon substrates. A total number of 25 spots per sample were 
printed with a 0.3 µ1 Ab solution per spot. Silicon samples were incubated in the 1 ° Ab 
for 30 minutes. Substrates were rinsed in PBS and immersed in 2% (w/v) BSA solution 
for 30 min. The rinsing step was repeated and the samples were transferred to a 1: 10,000 
anti-mouse IgG secondary antibody solution and incubated for 1 hour. Following another 
rinsing step in PBS, the samples were immersed in the chemiluminescent substrate 
solution following the manufacturer protocol (MichDiag, Rochester Ml). 
Autoradiography film was exposed to the sample for various time intervals. Experimental 
steps used for the immobilization of proteins and the detection of chemiluminescence are 
shown in figure 2. 7. 
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~1a- Quick Rinse in PBS (3X). 
~ b. Immerse sample in 2% BSA 
blocking solution. 
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Figure 2.7 -Immunoassay protocol used in antibody attachment and detection. A radiography 
image of one experiment is depicted in the center of this scheme. 
The chemiluminescence is generated from the reaction of an organic chemiluminescent 
substrate such as luminol or dioxetane substrate with horseradish peroxidase (HRP) 
conjugated to the secondary antibody. The reaction between Luminol and HRP in the 
presence of an oxidant (02 or H202) results in blue light emission. An example of 
chemiluminescence generation is shown in figure 2.8. 
0 
H,O, + Y¢:~ 
NH2 O 
Luminol 
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0 0 
HRP Y¢~- Y¢Q-
--- - I +hu(A.=425nm) o- ~ o- (Blue light) 
NH2 0 NH2 0 
Figure 2.8 - Generation of chemiluminescence through reaction between an organic substrate 
(luminol) with peroxidase. In this case, visible but dim blue light is emitted. (* indicates an 
excited state emitter). 
The intensity of chemiluminescence depends on the concentration of the enzyme, the 
substrate (i.e. luminol), peroxide as well as the presence of enhancer molecules. In this 
study, I have followed the manufacturer protocol in preparing the chemiluminescent 
substrate. In-depth discussion on the methods and mechanisms for generating 
chemiluminescence can be found elsewhere [ 46-48]. 
In the experimental scheme shown in figure 2.7, step 5 of the immunoassay is important 
for obtaining a good radiography image. In other words to reduce nonspecific adsorption 
of the secondary to the coverslip, the latter was coated with GPTS hence reducing 
background noise often seen in autoradiography images. 
2.4.2 RESULTS AND DISCUSSION 
Mouse anti-human collagen type IV IgG (1° Ab) was printed onto a GPTS coated silicon 
substrate. The presence of 1 ° Ab on the substrate was verified using a chemiluminescence 
tracer within the immunoassay procedure. A control experiment was done to verify that 
the presence of spot on the radiography image is not due to the nonspecific adsorption of 
the anti-mouse IgG conjugated to HRP to the substrate. The control measurements 
consisted of printing 0.3 µl spots of PBS buffer. In this case, the immunoassay shown in 
I 
' I 
49 
figure 2. 7 was repeated. The data for control and experimental measurements are 
summarized in figure 2.9. 
Before GPTS coating of Coverslip 
1° Ab printed Control (PBS spotted) 
i 
Exposure : 5 sec 
(a) 
After GPTS coating of Coverslip 
1° Ab printed Control (PBS spotted) 
i 
Exposure : 5 sec 
(b) 
After GPTS coating of Coverslip 
5 sec 10 sec 30 sec 1min 5min 
(c) 
Figure 2.9 - Data on primary antibody attachment to the GPTS-coated silicon oxide layer. 
As shown in figure 2.9, the treatment of coverslip with GPTS reduced the background 
noise observed in panel (a). The antibody array printed onto modified silicon substrates 
with GPTS-treated coverslip (panel (b)) is easier to distinguish in the radiography image 
than with untreated-coverslip (panel (a)). The chemiluminescence detected is due to the 
1 ° Ab-2° Ab interaction and not due to the nonspecific adsorption of the secondary 
antibody on the modified silicon substrates. A series of exposure of the radiography film 
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to the substrate is shown in panel (c). The background noise is totally reduced and 
positive signals are observed. However, missing spots are noticed as well as variability in 
the diameters of Ab spots. The antibody array was manually spotted using a micropipette, 
which is not a very accurate method for printing. An automated arrayer should be used to 
reduce the variability in spot diameters. The missing spots may be due to the 
nonhomogenous coating of the rather large substrate (lin2 ~ 6.45 cm 2). Typically, the 
size of substrates used for silanization in the literature is about 1 cm2• Nonetheless, GPTS 
allowed the immobilization of antibody to the oxide layer of silicon substrates. 
A dosage experiment using the radiography techniques was performed. Briefly, four 
solutions of 1 ° Ab were printed on GPTS coated substrate. The dilution factors used were 
1:50, 1:2500, 1:125000, and 1:3.75 xl06 (micromolar to nanomolar concentration). 
Autoradiography are not sensitive techniques, therefore, detecting almost picomolar 
range concentration of Ab was not possible. The presence of antibody on the surface was 
validated using the immunoassay used previously. Figure 2.10 presents results of the 
dosage experiment. 
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Figure 2.10 - Dosage experiment. Four dilution factors were used in the preparation of 1 ° Ab 
solutions. The template shown in panel (a) was follwoed during the spotting of antibodies 
solutions. The results of the dosage experiment are shown in panel (b). 
A template of the spotting strategy of the 1 °Ab solution is depicted in panel (a). As 
shown in panel (b) of figure 2.10, I was able to observe nanomolar concentration of the 1 ° 
Ab immobilized on the surface. The concentration for 1: 125000 1 ° Ab solution was 
estimated from the optical density of 1 :50 1 ° Ab solution. 
Up to this point, I have shown that mouse anti-human collagen type IV IgG (1 °Ab) 
can be immobilized to GPTS-coated silicon substrates. The presence of 1 ° Ab was 
verified using an immunoassay based on chemiluminescence detection. Although anti-
mouse IgG conjugated to HRP detected the presence of 1 ° Ab surface, the activity of 
antibody as it pertains to its binding ability, was not demonstrated. Therefore, an 
immunoassay based on anti-biotin IgG and HRP-tagged biotin interaction was used with 
anti-biotin lgG immobilized on the GPTS coated surface. The orientation of the anti-
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biotin lgG will affect the bioactivity of the antibody, i.e. an active anti-biotin IgG on 
GPTS coated surface will have its Fab portion exposed to the biotin solution. 
A series of dilutions for anti-biotin IgG was prepared in PBS. Using a pipette, 0.3 µl 
spots from each solution were spotted on GPTS-modified silicon substrates. The purpose 
for doing such measurement is to 1) determine a working dilution for mouse anti-biotin 
IgG and 2) study the bioactivity of anti-biotin lgG on GPTS-coated substrates. A 
template for the spotting procedure for anti-biotin IgG is shown in panel (a) of figure 
2.11. Subsequent steps were similar to the immunoassay described in figure 2. 7 with few 
exceptions. For instance, the step where a secondary antibody solution is added is 
replaced with a solution of 1:2000 of HRP-tagged biotin prepared from a 0.75 mg/ml 
stock solution. Coverslips were treated with GPTS to reduce background noise. The 
results of this experiment are shown in figure 2.11. Radiography images shown in panels 
(b) and ( c) are for different time intervals. 
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Figure 2.11 - Mouse monoclonal anti-biotin IgG printed on GPTS-coated silicon dioxide in 
1:100, 1:500, 1:1000, and 1:5000 dilution factors in the pattern shown in panel (a). Panels (b) and 
(c) depict radiography images of the assay to detect biotin conjugated to HRP. 
Spots shown in panels (b) and (c) are due to interaction between anti-biotin IgG and 
biotin conjugated to HRP. Clearly, anti-biotin IgG immobilized onto GPTS modified 
substrates retained its activity. For subsequent measurements a 1: 100 dilution factor was 
chosen for spotting anti-biotin IgG onto GPTS-coated silicon substrates. 
In another set of experiments, anti-biotin IgG was arrayed in a similar fashion as shown 
in figure 2. 7 on GPTS coated substrates. After a blocking solution, antibody-coated 
substrates were immersed either in a 1 :2000 biotin conjugate to HRP solution (prepared 
from a biotin stock solution of lmg/ml) or in a PBS solution. The latter solution (i.e. 
PBS) serves as ' control' measurement. The results form these experiments are shown in 
figure 2.12. 
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+ • 
Biotin-HRP 
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~-
Si/SiO2/GTS (c) 
Figure 2.12 - A 1:100 Mouse anti-biotin IgG was printed in a 6x5 array on two 1 in2 GPTS 
coated silicon oxide layers. One sample was immersed in a biotin-HRP solution while another 
sample was immersed in a buffer solution as shown panels (a) and (b). As expected, no signal 
was observed for panel (b ). 
In panel (c) of figure 2.12 (w/biotin), positive signals shown indicate that anti-biotin IgG 
is active on GPTS-coated substrates. In other words, HRP-tagged biotin is able to bind to 
the antigen-binding site of the anti-biotin IgG. For the 'control' measurements, the 
absence of chemiluminescence signals was expected as the anti-biotin coated substrate 
was incubated in a PBS solution free from HRP-tagged biotin. In fact, no 
chemiluminescent signal was observed as indicated in panel (c) of figure 2.12 (w/PBS). 
2.5 SUMMARY AND CONLCUSION 
In this chapter, I have shown using Infrared spectroscopy and Atomic force microscopy 
that glycidoxypropyltrimethoxysilane (GPTS) was bound to the oxide layer of silicon 
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substrates. GPTS-coated substrates were immobilized with analytes in array format 
(mouse anti-human collagen type IV IgG) to determine the attachment of proteins to 
GPTS. Using a tracer antibody (HRP-tagged anti-mouse IgG) solution, I was able to 
confirm, via the detection of chemiluminescence, that GPTS-coated substrates retained 
the analytes. Nonspecific adsorption of the HRP-tagged anti-mouse IgG to the GPTS-
coated substrate was verified using a 'control' experiment with PBS buffer spotted 
instead of primary antibody. The activity of Mouse anti-biotin IgG immobilized on 
GPTS-coated substrates was verified using an immunoassay with an HRP-tagged analyte. 
Anti-biotin IgG coated silicon substrates were able to recognize the presence of HRP-
tagged biotin in a buffer solution. This was an indication that the antigen-binding site of 
anti-biotin IgG was exposed to the surface, i.e. Fe-down orientation. Having determined 
the solution parameters as well as verified the antibody attachment, antibody was coupled 
to the transducer surface in an effort to build an immunoassay-based microdevice. The 
following chapter contains data on the integration of antibody with a detection modality. 
.J 
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CHAPTER3 
TOWARD AN IMMUNOASSAY-BASED BIOSENSOR 
3.1 INTRODUCTION 
Mouse anti-biotin lgG and Mouse anti-human collagen type IV retained their biological 
activity when immobilized onto GPTS coated surface as immunoassay results indicated. 
In developing an immunoassay-based biosensor, the coupling of biomolecules to the 
transducer surf ace must be performed. Immunoassay techniques will be used to validate 
the presence of antibody on the transducer; however, the detection modality is now based 
on avalanche photodiodes instead of radiography films. In this chapter, I describe the 
detection modality used, the coupling of antibody to the avalanche photodiode, and 
present data on APD detection of chemiluminescence light. First, a short review on the 
principle of avalanche photodiode and operation will be described. 
3.2 BACKGROUND ON AVALANCHE PHOTODIODES 
Current readout systems in the area of immunoassay-based biosensors involve the use of 
CCD techniques, autoradiography techniques, for labeled analytes. Although CCD 
techniques are good imaging techniques, slow response time in switching is one 
drawback [49]. Avalanche photodiodes (APDs) were chosen as they offer superior 
photon sensitivity (possibility of single-photon detection), fast switching time, and 
compatibility with complementary-metal-oxide-semiconductor (CMOS) technology, 
hence low cost. A typical structure for an APD device is shown in Figure 3.1. 
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Figure 3.1 - Principle of detection of a typical APD is depicted in panel (a). Panel (b) illustrates a 
more complex design of an APD developed by C. Jackson for single photon detection (redrawn 
from S. Kasap and C. Jackson et. al. [50, 51]). 
The n and p symbol refers to the type of chemical dopants added to the semiconductor 
where n refer to dopant with excess electron carrier and p to hole carrier. The principle of 
operation of an avalanche photodiode is described in panel (a) of figure 3.1. Briefly, a 
voltage is applied across the avalanche photodiode generating an electric field within the 
structure. Photons, with energy bigger than the band gap of the semiconductor, are 
absorbed within the active area of the avalanche photodiode generating an electron/hole 
pair. Because of the presence of high electric field, the electron is accelerated across the 
depletion region (area delimited by n+ and p shown in panel (a) of figure 3.1) and in 
doing so, exciting an adjacent carrier. The newly generated carrier will also be 
accelerated in the depletion region causing an excitation of another electron. An 
avalanche of carriers is observed within the APD generated through a multiplication 
phenomenon. The carriers are swept to the electrodes creating a measurable current, 
referred to as photocurrent. In-depth discussion on the principle of detection of complex 
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APD structures can be found elsewhere [49, 51 , 52]. Our interest in this work is to use 
APDs as sensitive detection modalities. 
Avalanche photodiodes operate in several modes; photodiode, avalanche photodiode, 
and Geiger mode. Depending on the biased voltage, APDs can operate as generic light 
detector or highly sensitive photodetector with single-photon detection capability. The 
latter modality, known as Geiger mode, is accomplished when the bias voltage across the 
APD is operated at a voltage larger than the breakdown voltage. An illustration showing 
the operational modes of APDs is presented in Figure 3.2. The applied voltage across the 
APD is shown on the x-axis while the measured current is depicted on the y-axis. 
A1.'al:mche Phorod:iode 
5 10 5 2 
Revern~ Bia~ Voltage 01) 
v : b; , 
V 
25 
Geige[ mode 
30 
Figure 3.2 - Current vs. Voltage (IV) curve of an avalanche photodetector. The Geiger-mode is 
the region where APD can detect single photon. (Reprinted from C. Jackson with permission[49]) 
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3.3 EXAMPLES OF APD APPLICATIONS 
Avalanche photodiodes are widely used as photon detectors for light detection in optical 
communications. Their use is also prevalent in fluorimetry, especially for single molecule 
detection. For examples, APDs were used as detection modalities for fluorescence signal 
in DNA sequencing machine. In their effort to develop a capillary electrophoresis for 
DNA sequencing purposes, Zhang et. al. used APDs to detect fluorescence signals from 
solution within each capillary [53]. As a proof of concept, a laser source was used to 
excite fluorescein molecules within each capillary. The limit of detection of APDs was 
around 130 fluorescein molecules from an injected solution of 2xl0-12 M. Crabtree et. al. 
also reported the high photon detection sensitivity of APDs in a similar study [54]. In 
addition, studies on single-molecule fluorescence detection employed APDs as detection 
systems. Gosch et. al. have demonstrated the use of APDs for single molecule detection 
in fluorescence correlation techniques as well as the determination of molecules 
concentrations [55]. Elsewhere, APDs were used to study conformational changes in p53 
protein-related peptides [56]. Neuweiler et. al. employed APDs to detect the quenching 
of a fluorescent dye by tryptophan, which were conjugated to the peptide being studied. 
Others [57] have used APDs to determine fluorescence lifetimes measurements. The use 
of APDs for photon detection, specifically single photon, has been demonstrated 
indicating the powerful use of such systems for developing immunoassay-based 
biosensor. 
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3.4 CHARACTERIZATION OF PHOTODIODES 
Avalanche Photodiodes were purchased from Carl Jackson ( at the time Photondetection 
System Inc. now at SensL Inc., Ireland). Photodetectors as received were on bare die, 
arranged in 1-D arrays. Microelectronic packaging was implemented to provide a better 
handling of APDs instead of using micromanipulator. The packaging of APDs was done 
for each linear array of detectors. The packaging process commonly involves wire 
bonding of the device to the pins of the package in addition to epoxy resin coverage for 
electrical isolation. To provide a venue for surface functionalization, a coverslip was 
bonded to the epoxy with one side exposed to air. This process was performed at 
Advotech Inc (Tempe, AZ). A picture of the packaged device can be viewed in figure 
3.3. 
24-pin package 
(a) (b) (c) 
Figure 3.3 -As shown in the design layout of an APD array, the size of the array is slightly above 
lmm2• Panel (b) shows a top-down view of a packaged APD. A magnified view of the dotted 
square is depicted in panel ( c ). 
Prior to antibody immobilization onto the packaged device, I verified some of the 
characteristics of APDs. Namely, diode characteristics of the APDs, breakdown voltage 
and light detection were determined. The former two properties were done using a 
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current-voltage analyzer, which measures the current as the voltage is swept across the 
APD. A typical diode will have nonlinear current-voltage characteristics. One of our 
colleagues helped in the testing of APD (Electrical Engineering department, Arizona 
State University). Diode characteristics for one APD were observed as figure 3.4 
indicates. In addition, the breakdown voltage for avalanche mode was between 26-27 V 
as shown in panel (b) of figure 3.4. 
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Figure 3.4-Diode Characteristic (a) and Breakdown voltage (b). 
Using light emitting diode (LED), a simple circuit was designed in order to test light 
detection characteristic of one APD. On a breadboard, a red LED in series with a resistor 
was placed right above the detector. The testing was done in a dark room to reduce stray 
light noise. The resistor used for the APDs was 98.6 kQ as measured using a voltmeter. 
The resistance value for the APD was chosen following results from C. Jackson [49]. The 
applied voltage across the APD was kept constant at 26. 72V whereas the voltage across 
the red LED was varied from 0-4 V. Oscilloscope probes were placed across the 
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resistance in series with the APD to measure the response of APD. Figure 3.5 shows the 
setup used in this case. 
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Figure 3.5 - APDs characterization using a red light emitting diode (LED). Shown in panels (a) 
and (b) are the circuits used to test the detection of light using APDs. The voltage across the red 
LED was varied from OV to 4V changing the intensity of light. The voltage was measured across 
the resistor of the APD being tested using an oscilloscope. Panels ( c) and ( d) show the voltage 
readout indicating the capability of APDs to detect light emanating from the red LED. 
As indicated in panel (d) of figure 3.5, the APD detected the response in light intensity as 
the voltage across the LED was varied. The next step is to integrate the APD with 
antibody discussed in the subsequent section. 
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3.5 APD DETECTION OF CHEMILUMINESCENCE 
Having determined that APDs are functioning as photodetectors, the immobilization of 
antibody onto the packages APD was performed. I have used the same immunoassays 
employed in chapter 2. Steps from the immunoassay procedure shown in figure 2. 7 were 
adjusted in this case due to differences in the size of substrates and use of a package. The 
procedure for printing antibody on the coverslip of the APD is described in the following 
section. 
3.5.1 EXPERIMENTAL PROCEDURE 
Our objective is to demonstrate that APDs are able to detect the chemiluminescence 
signal from the immunoassay. Prior to antibody attachment, I verified that APDs detect 
light. The diameter of the APD's active area used, unless stated otherwise, for all 
subsequent measurements was 20 µm biased at voltage of 26.72V. Prior each 
measurement, an oscilloscope was used to check the functional state of the APD. While a 
26. 72 V was applied across the APD, the voltage change was monitored on the 
oscilloscope as the room light was switched on. A change in voltage on the oscilloscope 
screen indicates that the APD is suitable for antibody attachment. 
i. GPTS coating of coverslip 
Within each APD package, a coverslip was bonded to the epoxy resin as previously 
described. The coverslip was rinsed with ethanol and blown dried with nitrogen. A stock 
solution of 2% (v/v) GPTS dissolved in hexane was used to coat the coverslip. For small-
sized coverslip within the APD package, 300 µL of the GPTS solution was. To prevent 
drying due to evaporation of hexane, I repeatedly added 300 µL of 2% GPTS solution at 
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several time intervals for a total time of 2 hours. Thereafter, the coverslip was rinsed 
twice with hexane. It was then blown dry with N2 stream and used immediately for 
antibody attachment. 
ii. IgG attachment to APD 
As a proof of principle, one spot of a 1 :500 (v/v) Mouse anti-human collagen type IV lgG 
(i.e. 1 ° Ab) solution dissolved in a PBS buffer was printed manually using a pipette. The 
volume of the 1 ° Ab droplet was 0.3 µl, which covered the whole APD array. Our goal is 
that 0.3 µl antibody solution be spotted on the coverslip directly above the 20µm APD 
(with 5µm guard ring). The immunoassay shown in figure 2.7 was followed with slight 
adjustment. For instance, the 1 ° Ab spot was left on the coverslip for 5 min before a 
rinsing step was performed. Should the 1 ° Ab solution be kept on the coverslip for longer 
time, the antibody will denature due to dehydration. A blocking solution of 2% (w/v) 
BSA in buffer was added to the APD package for 15 min. Another buffer rinse was 
performed and the APD package was place in a 50 ml tube containing 1:10,000 Anti-
mouse IgG conjugated to HRP. The incubation of APD package in the 2° Ab solution was 
for 40 min with agitation on a rocking plate during the last 20 min of incubation. The 
APD packaged was then rinsed with PBS buffer and placed in a 50 ml tube containing a 
10 ml solution of a chemiluminescent substrate. 
iii. APD detection of chemiluminescence. 
In a dark room, probes of the power supply set to 26.72 V and oscilloscope were 
connected to their corresponding wires placed in the breadboard. Depending on 
availability, I have used a Tektronix TDS 1012 (20 MHz) or an Agilent (MSO6104A, 
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1 GHz) oscilloscope. After the incubation in chemiluminescence, the antibody-coated 
APD was withdrawn with the package pins dried prior insertion into the breadboard. A 
black box was used to prevent stray light (power supply and oscilloscope screens) from 
interfering with measurements. Immediately, the power supply was turned on and the 
voltage measurements displayed on the oscilloscope were saved on a flash drive. Data 
acquisition of voltage was done for different time intervals reaching 1 hr. A typical 
oscilloscope displays at two different time sets are shown in figure 3.6. 
(a) (b) 
Figure 3.6 - Oscilloscope output. Voltage is labeled as y-axis (note 5V per division). Voltage 
values shown in panels (a) and (b) are taken at two different time intervals. The decrease in 
voltage is due to the decay of chemiluminescence over time. 
As a control experiment, a 0.3 µl spot of PBS buffer solution was printed on a GPTS 
coated coverslip of another APD package. To be consistent with our experiments, I only 
used 20 µm active area with 5 µm guard ring of the new APD. The immunoassay was 
repeated as described previously and data acquisition was done according to the previous 
procedure. The 'control' is done to prove that the chemiluminescence observed is due to 
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1 ° Ab-2° Ab interactions. However, 2° Ab present in the bulk solution add noise to our 
measurements. 
The attachment of Mouse anti-human type IV collagen was repeated for additional 
two trials. For each experiment, a control measurement was performed in parallel. 
Because of a limited number of available APD packages (2 packages), cleaning of used 
APD packages was performed. To make sure that past GPTS coating is removed, I used a 
1 :5 piranha solution. The coverslip for each APD package was cleaned by adding a 
droplet of the piranha solution. Careful consideration during piranha cleaning was taken 
to avoid etching the surrounding area of the package. The coverslip was scrubbed hastily 
with a cotton swab, rinsed thoroughly in water, and dried under a stream of nitrogen. The 
newly cleaned APD packages are ready for another round of GPTS coating. 
3.5.2 RESULTS AND DISCUSSION 
Following the first two immunoassay experiments, APD packages were cleaned as 
previously described in order to perform additional experiments. Prior to GPTS coating, 
each APD package was tested for light detection in a dark room simply by switching the 
light. A voltage change as the light was switched on/ off indicated the usability of the 
device. This 'crude' method was performed after further piranha cleaning. The 
performance of the APD did not vary dramatically after each cleaning step as figure 3.7 
shows. 
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Figure 3.7 - Reusability of APD packages after a piranha cleaning procedure. The number in 
parentheses on the x-axis indicates the number of piranha cleaning performed. The cleaning 
allowed us to use the two APD packages to perform eight experiments. 
Although cleaning APD packages proved useful, I cannot ascertain whether the piranha 
solution etched away the GPTS coating on the coverslip. I presume that this is highly 
likely due to the acidic nature of piranha solution. However, in designing a commercial 
immunoassay based microdevice, a less corrosive solution would be preferable to clean 
the devices to avoid damage to the APD package and waste management control. 
The attachment of mouse anti-human collagen type N IgG was verified using an 
immunoassay with a labeled secondary antibody, namely anti-mouse IgG conjugated to 
HRP. APDs were able to detect the chemiluminescence light as observed in figure 3.8. 
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Figure 3.8 - APD detection of chemiluminescence. 'Experiment' refers to 1 ° Ab attached to APD 
whereas ' control ' refers to PBS being printed on APDs. Clearly, APDs are sensing the secondary 
Ab recognition of the primary Ab as indicated by the difference in voltages between 
' experiments' (Li, □, and o) and 'controls ' (.A. , ■ , and•). 
Figure 3.8 contains data from six different measurements including experiment and 
control. As expected, the variation of the chemiluminescent intensity is observed with the 
control experiment showing a decreasing voltage over time. The intensity from this is due 
the bulk presence of secondary antibody that reacted with the chemiluminescent 
substrate. On the other hand, the presence of 1 ° Ab results in a typical chemiluminescent 
variation over time (e.g. open triangles in figure 3.8). One striking feature is the large 
variance observed for APD packages immobilized with 1°Ab (open symbols). The 
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position of the antibody spot printed on the coverslip will affect the signal intensity (in 
this case, the value of the voltage measured). A second speculation would relate to 
whether the difference between the amount of 1 ° Ab manually spotted is significant. One 
way to avoid such error is to use a mechanical printer, which deposits droplets with low 
variance in spot volume. On the upside, results shown in figure 3.4 indicate for one thing 
that APDs are able to detect chemiluminescence. Furthermore, there are clear differences 
between control values (noise signal) and true experimental values. Background 
subtraction should have been done in this case, however the discrepancies in the time 
intervals between control and experiment would not provide useful information. 
In addition, I have used APDs in conjunction with the immunoassay based on Mouse 
monoclonal anti-biotin IgG and HRP-tagged biotin. This assay will validate that the 
antibody retains its activity of the surface and the active site of the antibody is exposed to 
the analyte solution. The procedure for attaching Mouse anti-biotin IgG is identical to 
attachment of mouse anti-human collagen type IV. One difference is the dilution factor 
used which was 1:100 mouse anti-biotin IgG in PBS solution. The biotin-HRP solution 
was prepared from a 0.75 mg/ml with a dilution factor of 1:2000. For the control 
experiment, a buffer solution was added instead of the biotin conjugated to HRP to the 
sensors. Results from such experiments are depicted in figure 3.9. 
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Figure 3.9 - APD detection of chemiluminescence using an immunoassay based on anti-biotin 
IgG-biotin conjugated to HRP interactions. Experimental schemes used are shown. 
It is expected a priori that a control measurement using the immunoassay, i.e. no analytes 
added, should have voltage values fluctuated around zero as no HRP was used. However, 
figure 3.9 shows a different scenario for control measurements manifested by a rapid 
decay of the voltage values. In an effort to explain the voltage decay from control 
measurement, chemiluminescent substrates used for HRP were mixed together without 
adding protein conjugated to HRP. In the dark room, a visible yet dim chemiluminescent 
light was observed. It may be that the presence of oxygen in the atmosphere is reacting 
with the chemiluminescent substrates. In fact, chemiluminescence is often the result of a 
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reaction between a chemiluminescent substrate and oxygen. What is interesting about the 
voltage values for the control experiment is that an exponential decay curve can be fitted 
(red line in figure 3.9). This will help us perform a background subtraction as time values 
for 'control' and 'experiment' shown on the x-axis of figure 3.9 do not coincide. 
An exponential decay function was fitted to the voltage values for 'control' 
measurements. The fitted equation has the form: 
V = 21.696 · e-11 1.19279 Equation 3-1 
Where V represents voltage and t represents time in min. 
Using equation 3.1, time values from the experiment using biotin conjugated to HRP 
were inserted. The voltage values obtained using equation 3-1 are estimated values for 
the 'control' experiment. In doing so, I can perform background subtraction because 
signals are now "measured" at similar time intervals. A background subtraction was 
performed, i.e. voltage values estimated using the method just mentioned for 'control' 
were subtracted from voltage values for experiment based on biotin conjugated to HRP. 
The result of background subtraction is summarized in figure 3.10. 
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Figure 3.10-APD detection of chemiluminescence after background subtraction. The curve is 
more descriptive of the chemiluminescence decay in the presence of HRP. 
3.6 SUMMARY AND CONCLUSION 
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In this chapter, antibodies were immobilized on APDs using a silane-based coating 
characterized in chapter 2. APDs detection of chemiluminescence was observed. In 
addition, APDs were able to detect difference in voltage values between control and 
experiment measurements. The antibody-based biosensor combined the specificity of 
immunoassay with the sensitivity of avalanche photodiodes. In addition, the current 
device setup provides portability and can be manufactured at a low cost. However, device 
optimization will be required in order to elucidate the potential use of such device. I 
believe the on-chip readout and the miniaturization of the device are appealing features 
for developing commercial biosensors 
4.1 SUMMARY 
CHAPTER4 
SUMMARY AND FUTURE WORK 
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Immunoassay technologies are widely used for biomolecules identification in clinical 
diagnostics, screening food pathogen, and biomolecular research. Immunoassay 
techniques offer high specificity and sensitivity for molecular screening applications. 
When labeled analytes are used, an optical detection technique is often required. Most 
detection techniques have been based on fluorescence microscopy, autoradiography, or 
CCD imaging for chemiluminescence detection. Such techniques are not suited for 
fieldwork and at point of care situations. In addition, these techniques are expensive. 
Hence, the need for low cost, mobile commercial biosensors is desirable. In this work, I 
have presented an example of an immunoassay-based sensor with design specifications 
aforementioned. Our biosensor is based on the integration of immunoassay technology 
with an avalanche photodiode, a highly sensitive photondetection system. 
I have shown qualitatively that antibodies attached to the modified oxide layer of 
silicon substrates retained their bioactivity to recognize its specific analyte. This was 
demonstrated using an immunoassay whose components were mouse monoclonal anti-
biotin IgG and biotin molecules conjugated to HRP. In addition, APDs coupled to 
antibodies detected the chemiluminescence light from the previous immunoassay. There 
were clear differences between signals from control experiments and actual experiments. 
The small size of APO packages used for microsensing offers mobility, portability, fast 
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readout, and low cost. Further analysis of the immunoassay-based microdevice is needed 
to verify its use in screening multiple target, providing a user-friendly readout, and 
packaging. 
4.2 FUTURE WORK 
As a proof of concept, I have shown that APDs integrated with antibody are able to detect 
chemiluminescence light. Light detection data were displayed in graphical representation 
as shown in figures 3.8-3.10. Digital readout of chemiluminescence indicating the 
presence of analytes in solution is more preferred than the current graphical layout of data 
for a commercial readout. In addition, the readout system must perform background 
subtraction and output data indicating with statistical significance the presence of 
targeted molecules in solution. Prior to the development of a digital readout system, I 
need to address the following issues: 
1. The limit of detection of APDs should be determined. As mentioned in chapter 3 
APDs when operated in Geiger mode can detect single photon. In theory, picomolar 
and even femtomolar protein concentration should be detected. I had limited number 
of APD packages, and hence I was unable to perform such tests as such demand more 
than two APD packages. 
2. Use APDs in human sera to screen for a targeted disease-causing protein. As a proof 
of concept, I can follow in the footsteps of Askari et. al. [ 40] in designing antibody-
based biochip for cancer diagnostics. Serum samples from healthy patients could be 
isolated and mixed with a series of anti-p53 antibody concentration. Thereafter, APDs 
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attached to p53 proteins will be used to detect the presence of anti-p53 antibody. I 
need to mention that conjugation of anti-p53 antibody to HRP should be performed. 
3. Another projected study should focus on using a microarray printer to spot protein 
solution onto APDs array. Each protein spot should be printed on top of each APD 
within a linear array of APDs. This step requires APDs with active area larger 
Another aspect that should be addressed is the need for larger active area than 20µm 
(used in this project However, APDs with larger active area are commercially 
available. The question then is demonstrating the integration of microarray 
technology with CMOS-based APDs. In addition, demonstrating high throughput 
screening using the currently developed immunoassay microdevice will be a step 
closer to commercialization. Indeed, microarray technology potential for high density 
printing of protein have been demonstrated [9, 26, 36, 38]. Microarray technology 
combined with CMOS-based APD technology will be useful in developing a 
commercial high throughput device for biosensing application. 
4. Last, but not least, research effort should focus on improving the optics of the 
immunoassay-based microdevice related to including antireflection coating to reduce 
photon loss due to reflection. In addition, a system of lenses is desired for each 
antibody microarray that will focus chemiluminescence from each protein spot onto 
APDs. Micro-optics technology could be used to design a microlens array, which will 
be incorporated on the coverslip of APD package. The microlens system will improve 
the optical characteristic of the immunoassay-based microdevice. In fact, Silica-based 
microlens, which can be functionalized and immobilized with antibodies, are 
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available commercially. A virtual setup of the device for lx4 APD array with a 
microlens array is illustrated in figure 4.1. 
Microlens array __ 
Coverslip 
APD package ---
Figure 4.1 - Improving the optics of the developed immunoassay-based microdevice. 
Using a microlens system, light from immunoassay can be focused onto APDs as shown 
in figure 4.1. The coverslip in the layout shown in figure 4.1 provides a smooth surface 
for fabricating the microlens system. 
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